• Mubritinib (TAK 165): Targeting Complex I in Cancer Research

  2026-04-22

  Mubritinib (TAK 165) uniquely inhibits mitochondrial complex I, offering selective cytotoxicity for chemotherapy-resistant AML and KSHV-driven lymphomas. This guide translates cutting-edge findings into actionable workflows, troubleshooting tips, and comparative insights, empowering advanced cancer and virology research.

• EGTA (Egtazic Acid): Precision Calcium Chelation in Research

  2026-04-22

  EGTA, an aminopolycarboxylic acid known as egtazic acid, acts as a selective calcium chelator with high affinity. It is widely used for modulating calcium signaling pathways and protecting cells from calcium-mediated cytotoxicity. High-purity EGTA from APExBIO (SKU B7195) is validated for research applications including neuroprotection and apoptosis assays.

• Brefeldin A in Cancer Cell Biology: Protocols, ER Stress, an

  2026-04-21

  Brefeldin A (BFA) is a powerful tool for dissecting ER stress and apoptosis in cancer research, with unique advantages in tracking protein trafficking and vesicle dynamics. This article delivers evidence-backed workflow enhancements, troubleshooting tips, and insights from recent advances in ER protein quality control, all anchored by APExBIO’s high-purity BFA.

• CHIR-99021 (CT99021): Optimizing Stem Cell and Neuroimmune W

  2026-04-21

  CHIR-99021 (CT99021) is a benchmark GSK-3 inhibitor, driving robust pluripotency maintenance, directed differentiation, and advanced neuroimmune modeling. This guide delivers actionable protocols and troubleshooting insights for maximizing reliability and performance with APExBIO’s CHIR-99021 across stem cell, neuronal, and TGF-β/Nodal signaling research.

• Protease Inhibitor Cocktail EDTA-Free: Workflow Enhancements

  2026-04-20

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO enables superior protein preservation in workflows sensitive to proteolysis and divalent cations. Its robust, EDTA-free formulation unlocks advanced applications in phosphorylation analysis, immunoprecipitation, and lysosomal repair studies—empowering reproducibility even under extreme cellular stress.

• Norovirus Exploits NINJ1 for Selective Viral Protein Secreti

  2026-04-20

  This study uncovers how murine norovirus (MNoV) hijacks the host membrane rupture factor NINJ1 to selectively secrete its NS1 protein, revealing a previously unknown mechanism for viral protein export during apoptosis. The work provides key insights into regulated plasma membrane rupture and its implications for both viral pathogenesis and programmed cell death.

• Biotin-16-UTP: Applied RNA Labeling for Detection & Purifica

  2026-04-19

  Biotin-16-UTP empowers sensitive and reproducible RNA detection, purification, and interaction studies through robust biotin-streptavidin binding. Discover optimized experimental workflows, troubleshooting strategies, and advanced applications that leverage APExBIO’s validated biotin-labeled uridine triphosphate for high-impact molecular biology research.

• GW4064 (SKU B1527): Reliable FXR Agonist for Reproducible As

  2026-04-18

  This article addresses the critical laboratory challenges encountered in FXR pathway, cell viability, and fibrosis models by leveraging GW4064 (SKU B1527), a potent non-steroidal FXR agonist. Drawing from peer-reviewed studies and product specifications, it offers scenario-driven, evidence-based solutions for assay selection, protocol optimization, and data interpretation—empowering researchers to achieve reproducible, high-sensitivity results.

• Differential Volatiles in Chuanxiong Rhizome: Insights for C

  2026-04-17

  This study employs SPME-GC×GC-MS and network pharmacology to map distinct bioactive volatile profiles in the cortex and pith of Ligusticum chuanxiong rhizome for coronary heart disease (CHD) intervention. Key findings highlight Fenipentol as a major cortex compound with unique mechanistic links to cardiovascular pathways, offering new directions for targeted herbal and molecular research.

• Biotin-16-UTP: Strategic RNA Labeling for Translational Impa

  2026-04-16

  This thought-leadership article explores Biotin-16-UTP’s mechanistic advantages and strategic applications in translational RNA research. We bridge recent discoveries in lncRNA biomarker biology, highlight competitive differentiation, and provide actionable guidance for optimizing RNA detection and purification workflows. By integrating evidence from hepatocellular carcinoma research and best practices in RNA labeling, this piece empowers researchers to leverage biotin-labeled uridine triphosphate for advanced molecular investigations.

• SC 79 Akt Activator: Optimizing Neuroprotection and Cell Sur

  2026-04-15

  SC 79, a cytosolic Akt activator from APExBIO, transforms neuroprotection and cell survival workflows by enabling precise, reproducible Akt pathway activation. This article guides researchers through optimized protocols, practical troubleshooting, and translational insights, bridging mechanistic research with robust experimental design.

• CHIR 99021 trihydrochloride: Reliable GSK-3 Inhibition for A

  2026-04-14

  This article addresses persistent challenges in cell viability and organoid assays, detailing how CHIR 99021 trihydrochloride (SKU B5779) from APExBIO enables reproducible, sensitive modulation of GSK-3 activity. Drawing on recent literature and real-world workflow scenarios, it guides biomedical researchers in optimizing insulin signaling, stem cell maintenance, and glucose metabolism experiments.

• Belinostat (PXD101) in Precision Epigenetic Cancer Assays

  2026-04-13

  Explore Belinostat (PXD101) as a pan-HDAC inhibitor for robust epigenetic cancer research. This article delivers a unique assay-focused analysis, bridging mechanistic insights with advanced in vitro evaluation for bladder and prostate cancer models.

• ZCL278 (SKU A8300): Precision Cdc42 Inhibition in Cell Assay

  2026-04-12

  This article distills real-world laboratory challenges in cell viability, proliferation, and cytotoxicity assays, offering scenario-driven guidance on leveraging ZCL278 (SKU A8300) for precise and reproducible Cdc42 pathway inhibition. By integrating recent mechanistic insights and protocol best practices, scientists can optimize workflow fidelity and data interpretation with this selective small molecule inhibitor.

• YTHDF2 Regulates Hippocampal m6A mRNA Decay and Memory Forma

  2026-04-12

  This study reveals that inhibiting YTHDF2-mediated m6A mRNA degradation in the mouse forebrain elevates synaptic protein synthesis and enhances hippocampus-dependent memory. The findings clarify the mechanistic role of m6A reader proteins in neural plasticity while suggesting new entry points for studying epitranscriptomic regulation of cognition.

15953 records 1/1064 page Next 12345 下5页 Last page